Radiation and ATM inhibition: the heart of the matter

Insights

The ATM gene is crucial for radiosensitivity in human cells. However, in mice, Atm gene deletion showed less radiation sensitivity in normal heart cells compared to tumor cells.

Area of Science:

  • Radiation oncology
  • Cancer biology
  • Genetics

Background:

  • In vitro studies indicate ATM deficiency causes extreme radiosensitivity in human cells.
  • ATM (Ataxia-Telangiectasia Mutated) is a key DNA damage response protein.

Purpose of the Study:

  • To investigate the in vivo radiosensitizing effect of Atm gene deletion in a murine sarcoma model.
  • To compare the radiosensitivity of normal cardiac endothelium versus tumor endothelium lacking functional ATM.

Main Methods:

  • Utilized a murine sarcoma model with Atm gene deletion.
  • Assessed the radiosensitizing effect on normal cardiac endothelium and tumor endothelium.

Main Results:

  • Deletion of the Atm gene had a significantly lower radiosensitizing effect on normal cardiac endothelium compared to rapidly proliferating tumor endothelia.
  • This contrasts with the established radiosensitivity of ATM-deficient human cell lines.

Conclusions:

  • The role of ATM in radiation sensitivity is less general in vivo than previously assumed from in vitro data.
  • The potential of ATM inhibitors as radiosensitizers may be context-dependent, requiring further investigation in vivo.

Related Concept Videos

Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
31.2K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
8.5K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
2.3K
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
13.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K